Trial NCT03146403

View at ClinicalTrials.gov 
Org. Study IDs: GEN-003-005

Last trial update was posted on 2019-02-19

MeSH Interventions

Vaccines

MeSH Conditions

Communicable Diseases Herpes Genitalis Herpes Simplex Herpesviridae Infections Infections

Other Conditions

Genital Herpes HSV-2 Infection

Stopping Reasons

2017 business decision to cease GEN-003 spending.

Limitations And Caveats

Small numbers of enrolled subjects likely led to a lack of statistical power. After a 2017 business decision to cease GEN-003 spending, the outcome measures were reduced to 6 months of follow up, rather than the originally planned 12 months.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID